Time‐lapse imaging points towards a non‐toxic, mainly immune‐driven mode of action of ingenol mebutate in the treatment of anogenital warts
暂无分享,去创建一个
B. Homey | E. Bünemann | P. Gerber | S. Braun | J. Baran
[1] P. Gerber,et al. Ingenol mebutate for the management of genital warts in sensitive anatomic locations. , 2017, Journal of the American Academy of Dermatology.
[2] H. Haenssle,et al. Tumor-Preferential Induction of Immune Responses and Epidermal Cell Death in Actinic Keratoses by Ingenol Mebutate , 2016, PloS one.
[3] S. Braun,et al. Erfolgreiche Behandlung von perianalen Condylomata acuminata mit Ingenolmebutat , 2016, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.
[4] F. Bai,et al. Neutrophil in viral infections, friend or foe? , 2013, Virus research.
[5] J. Lord,et al. Ingenol mebutate: induced cell death patterns in normal and cancer epithelial cells. , 2012, Journal of drugs in dermatology : JDD.
[6] S. Tyring,et al. Dual mechanism of action of ingenol mebutate gel for topical treatment of actinic keratoses: rapid lesion necrosis followed by lesion-specific immune response. , 2012, Journal of the American Academy of Dermatology.
[7] D. Kavanagh,et al. The anti-tumor agent, ingenol-3-angelate (PEP005), promotes the recruitment of cytotoxic neutrophils by activation of vascular endothelial cells in a PKC-δ dependent manner , 2008, Cancer Immunology, Immunotherapy.
[8] D. Kavanagh,et al. Neutrophils Are a Key Component of the Antitumor Efficacy of Topical Chemotherapy with Ingenol-3-Angelate1 , 2006, The Journal of Immunology.
[9] P. Blumberg,et al. Characterization of the interaction of ingenol 3-angelate with protein kinase C. , 2004, Cancer research.
[10] W. Maśliński,et al. Protein kinase c-dependent pathway is critical for the production of pro-inflammatory cytokines (TNF-alpha, IL-1beta, IL-6). , 1999, Cytokine.